Aaron Schuchart - 11 Aug 2021 Form 4 Insider Report for LUMOS PHARMA, INC.

Role: Chief Business Officer
Signature: /s/ Ryan Trytten, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 11 Aug 2021
Net transactions value: +$14,819
Form type: 4
Filing time: 13 Aug 2021, 16:32:42 UTC
Previous filing: 03 Jun 2021
Next filing: 03 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUMO	Common Stock	Purchase	$2,205	+300	+29%	$7.35	1,337	11 Aug 2021	Direct	F1, F2
transaction	LUMO	Common Stock	Purchase	$12,614	+1,700	+127%	$7.42	3,037	12 Aug 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 695 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
F2	Includes 109 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on June 30, 2021.

Content

Includes 695 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

Includes 109 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on June 30, 2021.